| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
|
Blood
|
2004
|
3.61
|
|
2
|
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.
|
Blood
|
2002
|
3.56
|
|
3
|
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
|
Blood
|
2011
|
3.02
|
|
4
|
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
|
Blood
|
2008
|
2.35
|
|
5
|
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
|
Blood
|
2008
|
2.34
|
|
6
|
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.
|
Biol Blood Marrow Transplant
|
2011
|
1.88
|
|
7
|
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
|
Biol Blood Marrow Transplant
|
2009
|
1.84
|
|
8
|
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
|
J Clin Oncol
|
2011
|
1.74
|
|
9
|
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.
|
Blood
|
2009
|
1.70
|
|
10
|
One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.
|
Biol Blood Marrow Transplant
|
2010
|
1.69
|
|
11
|
Outcome of transplantation for myelofibrosis.
|
Biol Blood Marrow Transplant
|
2009
|
1.68
|
|
12
|
Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.
|
J Clin Oncol
|
2013
|
1.66
|
|
13
|
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
|
Biol Blood Marrow Transplant
|
2006
|
1.63
|
|
14
|
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
|
J Clin Oncol
|
2008
|
1.63
|
|
15
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2003
|
1.58
|
|
16
|
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
|
Biol Blood Marrow Transplant
|
2006
|
1.58
|
|
17
|
Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl.
|
Int J Epidemiol
|
2004
|
1.58
|
|
18
|
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.
|
Blood
|
2004
|
1.58
|
|
19
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2009
|
1.53
|
|
20
|
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.
|
Blood
|
2013
|
1.50
|
|
21
|
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
|
Biol Blood Marrow Transplant
|
2006
|
1.49
|
|
22
|
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
|
Blood
|
2004
|
1.47
|
|
23
|
Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1-, IL-17-, and G-CSF-dependent manner.
|
Blood
|
2012
|
1.46
|
|
24
|
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
|
Blood
|
2008
|
1.42
|
|
25
|
Excess diagnosis of non-Hodgkin's lymphoma during spring in the USA.
|
Leuk Lymphoma
|
2007
|
1.40
|
|
26
|
Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies.
|
Infect Control Hosp Epidemiol
|
2002
|
1.30
|
|
27
|
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
|
Biol Blood Marrow Transplant
|
2009
|
1.22
|
|
28
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2010
|
1.20
|
|
29
|
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.
|
Br J Haematol
|
2007
|
1.20
|
|
30
|
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.
|
Blood
|
2004
|
1.18
|
|
31
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2008
|
1.16
|
|
32
|
Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.
|
Biol Blood Marrow Transplant
|
2010
|
1.15
|
|
33
|
Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.
|
Biol Blood Marrow Transplant
|
2009
|
1.14
|
|
34
|
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
|
Blood
|
2005
|
1.14
|
|
35
|
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.
|
J Clin Microbiol
|
2004
|
1.11
|
|
36
|
Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
|
Biol Blood Marrow Transplant
|
2010
|
1.11
|
|
37
|
Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review.
|
Biol Blood Marrow Transplant
|
2011
|
1.11
|
|
38
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2007
|
1.10
|
|
39
|
Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis.
|
Biol Blood Marrow Transplant
|
2007
|
1.10
|
|
40
|
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission.
|
Br J Haematol
|
2002
|
1.06
|
|
41
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.
|
Biol Blood Marrow Transplant
|
2010
|
1.06
|
|
42
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2005
|
1.02
|
|
43
|
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
|
Biol Blood Marrow Transplant
|
2004
|
1.00
|
|
44
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2006
|
0.98
|
|
45
|
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
|
Biol Blood Marrow Transplant
|
2008
|
0.97
|
|
46
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.
|
Biol Blood Marrow Transplant
|
2011
|
0.96
|
|
47
|
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.
|
Mycopathologia
|
2005
|
0.94
|
|
48
|
Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results.
|
Health Serv Res
|
2011
|
0.94
|
|
49
|
A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation.
|
Biol Blood Marrow Transplant
|
2010
|
0.92
|
|
50
|
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.
|
Clin Lymphoma Myeloma Leuk
|
2010
|
0.90
|
|
51
|
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.
|
Biol Blood Marrow Transplant
|
2011
|
0.90
|
|
52
|
A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
|
J Immunol
|
2012
|
0.89
|
|
53
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement.
|
Biol Blood Marrow Transplant
|
2012
|
0.89
|
|
54
|
Arterial thrombosis in four patients treated with thalidomide.
|
Leuk Lymphoma
|
2005
|
0.88
|
|
55
|
Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence.
|
Blood
|
2005
|
0.88
|
|
56
|
The effect of smoking on allogeneic transplant outcomes.
|
Biol Blood Marrow Transplant
|
2009
|
0.88
|
|
57
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.
|
Biol Blood Marrow Transplant
|
2011
|
0.88
|
|
58
|
Granzyme B-mediated damage of CD8+ T cells impairs graft-versus-tumor effect.
|
J Immunol
|
2012
|
0.87
|
|
59
|
Comparison of twin and autologous transplants for multiple myeloma.
|
Biol Blood Marrow Transplant
|
2008
|
0.87
|
|
60
|
Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients.
|
Leuk Res
|
2005
|
0.87
|
|
61
|
Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.
|
Biol Blood Marrow Transplant
|
2013
|
0.86
|
|
62
|
Multiple myeloma: future directions in autologous transplantation and novel agents.
|
Biol Blood Marrow Transplant
|
2013
|
0.86
|
|
63
|
Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2010
|
0.85
|
|
64
|
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
|
Biol Blood Marrow Transplant
|
2006
|
0.84
|
|
65
|
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.
|
J Clin Oncol
|
2002
|
0.84
|
|
66
|
Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease.
|
Biol Blood Marrow Transplant
|
2009
|
0.84
|
|
67
|
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2008
|
0.83
|
|
68
|
Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2006
|
0.82
|
|
69
|
HLA DR15 and immunobiologic outcomes.
|
Biol Blood Marrow Transplant
|
2007
|
0.81
|
|
70
|
Remestemcel-L for acute graft-versus-host disease therapy.
|
Expert Opin Biol Ther
|
2013
|
0.81
|
|
71
|
The Chernobyl childhood leukemia study: background & lessons learned.
|
Environ Health
|
2004
|
0.80
|
|
72
|
Francis P. McCarthy, pioneer in oral medicine.
|
J Hist Dent
|
2008
|
0.80
|
|
73
|
A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT.
|
Biol Blood Marrow Transplant
|
2009
|
0.79
|
|
74
|
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
|
Biol Blood Marrow Transplant
|
2008
|
0.79
|
|
75
|
Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.
|
Leuk Lymphoma
|
2011
|
0.79
|
|
76
|
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
|
Biol Blood Marrow Transplant
|
2007
|
0.79
|
|
77
|
Reversible cardiotoxicity with tyrosine kinase inhibitors.
|
Clin Adv Hematol Oncol
|
2010
|
0.78
|
|
78
|
Unrelated donor allogeneic hematopoietic cell transplantation is underused as a curative therapy in eligible patients from the United States.
|
Biol Blood Marrow Transplant
|
2013
|
0.78
|
|
79
|
Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.
|
Biol Blood Marrow Transplant
|
2005
|
0.78
|
|
80
|
Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.
|
Cytometry B Clin Cytom
|
2010
|
0.77
|
|
81
|
Development of a pharmacokinetic and Bayesian optimal sampling model for individualization of oral busulfan in hematopoietic stem cell transplantation.
|
Ther Drug Monit
|
2006
|
0.77
|
|
82
|
Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?
|
Curr Hematol Malig Rep
|
2015
|
0.77
|
|
83
|
Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration.
|
Biol Blood Marrow Transplant
|
2013
|
0.76
|
|
84
|
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
|
Transplantation
|
2004
|
0.76
|
|
85
|
Common genetic variants are associated with accelerated bone mineral density loss after hematopoietic cell transplantation.
|
PLoS One
|
2011
|
0.76
|
|
86
|
Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples.
|
Cytometry B Clin Cytom
|
2014
|
0.75
|
|
87
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.
|
Biol Blood Marrow Transplant
|
2003
|
0.75
|
|
88
|
β2 Adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells.
|
J Clin Invest
|
2019
|
0.75
|
|
89
|
Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies.
|
Leuk Lymphoma
|
2008
|
0.75
|
|
90
|
Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
0.75
|
|
91
|
Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
|
Pharmacotherapy
|
2014
|
0.75
|
|
92
|
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy.
|
Ann Hematol
|
2015
|
0.75
|
|
93
|
Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
0.75
|
|
94
|
Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.
|
J Natl Compr Canc Netw
|
2012
|
0.75
|